• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags $3B deal

$3B deal News

Business

Regeneron and Fujifilm Forge $3B Biotech Alliance to Enhance US Pharmaceutical Production

Michael Lee 23 Apr, 2025

Regeneron Pharmaceuticals Inc. has signed a $3 billion deal with Fujifilm Diosynth Biotechnologies to produce biologic medicines in North Carolina, marking a significant investment...

Popular News

  • Business

    Nvidia Stock Plummets 5% to September Lows Amid New US Tariff Announcements

    04 Feb, 2025
  • Economy

    March Sees US Trade Deficit Soar to $140.5B, Marking a Significant Monthly Increase

    06 May, 2025
  • Market

    Gold Soars to Unprecedented Heights: A 1.12% Leap to $2,892 Amid Global Tariff Announcements

    11 Feb, 2025
  • Business

    Pilots' Association Slams Air India Crash Probe: Claims Investigation Lacks Basics and Unfairly Targets Crew

    14 Jul, 2025
  • Economy

    Electric Dreams Fuel Surge: Motorbike Sales Jump 6.4% in First Half Amidst Green Revolution

    20 Jul, 2025
  • Business

    Empowering Future Leaders: The Innovative Approach of Billabong High International School

    18 Mar, 2025
  • Stock

    Kim Deok-joo Advocates for Personalized Health Functional Food Market Success at 2025 Conference

    28 Jul, 2025
  • Business

    BP Welcomes Albert Manifold as New Chairman, Signaling a New Era for the Energy Giant

    21 Jul, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.